The Australian Melanoma Research Foundation is a not-for-profit charity organisation, established by a group of dedicated volunteers to provide funding for research into novel immune based treatments for melanoma. We also have a strong commitment to melanoma awareness and education within the community, as well as providing a support service to anybody affected by melanoma or seeking information regarding melanoma treatment.
EMOTIV - Melanoma Vaccine Trial
Enhancing melanoma outcomes using a timed immunotherapy vaccine
The AMRF is a major sponsor of the EMOTIV trial for patients with advanced melanoma, which is continuing at the Royal Adelaide Hospital.
Eligibility: The study is for South Australian patients with advanced (Stage IV or III) melanoma, which cannot be removed by surgery.
Aims: To test a new approach to administering a melanoma vaccine, which had excellent results in a previous study, when it was given at regular intervals (18% complete response rate and 13% 5-year survival times). The vaccine doses will be either 'timed' or not-timed' with the patients own immune system fluctuations. The potential is to improve the effectiveness of the vaccine. The vaccine has virtually no side effects and early results of this study are remarkable.
Contact: If you are interested, would like to know if you are eligible for entry, or would like more information then please contact firstname.lastname@example.org or call (08) 8222 4439
Note: Eligibility criteria apply